CD30+ anaplastic large cell lymphoma

Clinical trials for CD30+ anaplastic large cell lymphoma explained in plain language.

Never miss a new study

Get alerted when new CD30+ anaplastic large cell lymphoma trials appear

Sign up with your email to follow new studies for CD30+ anaplastic large cell lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Supercharged T-Cells take on stubborn lymphomas

Disease control Recruiting now

This early-stage trial is testing a new type of immunotherapy for people with CD30-positive blood cancers that have come back or not responded to treatment. The therapy uses a patient's own immune cells, which are collected, modified with a special antibody, and then given back t…

Matched conditions: CD30+ ANAPLASTIC LARGE CELL LYMPHOMA

Phase 1 • Sponsor: Medical College of Wisconsin • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC

CD30+ anaplastic large cell lymphoma

Get alerted when new CD30+ anaplastic large cell lymphoma trials appear

Supercharged T-Cells take on stubborn lymphomas